But given their high prices a month's supply of Wegovy costs $1,350 (1,062) and onerous side effects which can include nausea, stomach pain and heartburn, the question has always been, what happens when people stop taking them
Since 2014, Semaglutide GLP-1 injections have been FDA-approved for use as a means to supplement weight loss for those who are obese or who suffer from weight-related medical problems
We emphasize that while semaglutide GLP-1 can be a powerful aid, combining the treatment with a nutritious diet and regular physical activity can further enhance its effectiveness
Although this medication is not yet FDA-approved for the treatment of obesity, it was granted fast track designation for this indication in October 2022 and current results look promising
Similar results were found in a clinical study in patients with T2DM, where administration of liraglutide, but not metformin, increased the relative abundance of Akkermansia , which is often associated with the improvement of gastric mucosa and also becomes severely depleted in diabetic patients [115]